Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Christopher & Banks Corporation (CBK), Chico’s FAS, Inc. (CHS): After a Triple Digit Gain, Can This Retailer Continue its Momentum?

Midwestern women’s retailer Christopher & Banks Corporation (NYSE:CBK) has a new CEO, a new product strategy, and plans for new stores, all of which have stoked investors’ enthusiasm and resulted in a strong stock price gain versus the retail industry average over the past year.  After poor inventory management led to sub-30% gross margins in 2010 and 2011, management finally took drastic measures. The company closed unprofitable stores and returned its product mix to the simple styles and value price points that resonated with its core customer base.  The result has been higher customer traffic and better comparable store sales that led to more productive stores.  However, with tough competition in the sector, is Christopher & Banks Corporation (NYSE:CBK) currently a good bet?

Chart forChristopher & Banks Corporation (CBK)

What’s the value?
Christopher & Banks Corporation (NYSE:CBK) is a value-priced retailer of casual and wear-to-work apparel and accessories for women. The company targets the 45-to-60 age demographic with a core selection of knit tops, sweaters, and pants.  As management has acknowledged, the company tried to get too fashionable and varied with its clothing styles at prices not conducive to its customer base, leading to sharp markdowns and a gross margin that hit an annual low of 24.4% in 2011.  Fortunately, management saw the writing on the wall and subsequently launched an improvement plan that included shrinking both its retail store footprint and its number of distinct clothing styles, as well as dropping the average prices of its products.

Christopher & Banks Corporation (NYSE:CBK)

In FY2013, the fruits of management’s labor have started to find lasting traction, with comparable store sales up 7.7% and a return to operating profitability.  Counter-intuitively, Christopher & Banks Corporation (NYSE:CBK)’s product price reductions have led to greater customer traffic and lower overall inventory markdowns, which ultimately produced a higher gross margin.  More importantly, rationalizing product lines has created cost savings in the supply chain, resulting in positive operating cash flow and the ability to pursue growth, and the company plans for roughly twenty store openings per year.

Chasing the competition
Of course, Christopher & Banks Corporation (NYSE:CBK) has some work to do to catch its more profitable, growth-minded competitors, like Chico’s FAS, Inc. (NYSE:CHS).  The company has a namesake chain that is of comparable size to Christopher & Banks Corporation (NYSE:CBK), with roughly 616 stores, and it targets a similar customer base of middle class working women.  Chico’s FAS, Inc. (NYSE:CHS) is also trying to keep the upwardly mobile members of its customer base within the corporate fold through its newer, premium priced retail concepts, including White House/Black Market and Boston Proper.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.